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Summary
We synthesized and cloned cDNA from human peripheral blood mononuclear cell (PBMC)
transcripts that were hybrid selected bypCRP5, a liver C-reactive protein (CRP)-specific cDNA
(Woo, P ., J.R . Korenberg, andA.S. Whitehead . 1985 .J . Biol. Chem . 260:13384) . Three hybrid-
selected cDNA clones, HScDNA1, HScDNA3, and HScDNA8, were isolated and characterized .
Nucleotide sequence analysis of the 5' end of the smaller clones, HScDNA1 and HScDNA8,
demonstrated that these two PBMC clones are homologous to the 3' and 5' ends, respectively,
of pCRP5 . Our largest clone, HScDNA3, is larger than pCRP5, extending beyond both the
5' and 3' limits ofpCRP5 . Therefore, HScDNA3 was coded by human PBMC and not by the
hybrid selection vehicle, pCRP5 . HScDNA3 lacks the intervening sequence verifying that this
clone is DNA made from a PBMC mRNA and not genomicDNA . The complete nucleotide
sequence revealed that HScDNA3 is greater than 99% homologous to the CRP gene. These
results demonstrate that PBMC express the CRP gene. Based on our previous report, which
shows that peripheral blood cells synthesize a peptide recognized by anti-CRP (Kuta, A.E ., and
L.L . Baum . 1986 .JExp . Med . 164:321), in conjunction with the data presented here, we conclude
that human PBMC can synthesize CRP.
reactive protein (CRP), the major acute phase reactant
in humans, is synthesized by hepatocytes and secreted
into the serum (1) . Our laboratory demonstrated thathuman
PBL synthesize a peptide recognized by anti-CRP and that
monocytes do not (2) . The ability to eliminate NK function
with anti-CRP indicates that this peptide is expressed on the
surface of these cytolytic effector cells (3) . Ikuta et al . (4)
also demonstrated extrahepatic synthesis of a peptide recog-
nized by anti-CRP using unstimulated human PBMC. The
studies reported here were performed to determine whether
the anti-CRP binding peptide synthesized byPBMC is CRP
or an antigenically related peptide. CRP-related transcripts
produced in PBMC were isolated and sequenced to defini-
tively determine whether the CRP-related transcripts repre-
sent CRP, the CRP pseudogene, or another antigenically
related peptide. Three PBMC hybrid-selected cDNA clones
(HScDNA), HScDNA1, HScDNA3, and HScDNA8, were
sequenced and determined to have identity with pCRP5 . Fur-
thermore, the complete sequence ofthe largest clone, HScDNA3,
revealed that this clone represents a PBMC transcript specific
for CRP and provides definitive proof that PBMC transcribe
CRP This finding confirms reports of extrahepatic synthesis
of CRP.
Materials and Methods
Isolation ofPBMC.
￿
From each of four normal healthy human
individuals, 100 ml of whole blood was collected into sodium
heparin, pooled, and mixed with an equal volume ofSepracell-MN
(Sepratech Corp ., Oklahoma City, OK) . PBMC were isolated and
the cell count and viability were determined by trypan blue ex-
clusion .
Cloning ofHScDNA .
￿
Acid guanidinium thiocyanate-phenol-
chloroform extraction (5) was used to isolate total RNA from
PBMC . The plasmidpCRP5 constructed by Dr . Alexander White-
head (Harvard Medical School, Boston, MA) (6), was a generous
gift from Dr. Harvey Colton (Washington University, St . Louis,
MO) . The 1.6-kb Pstl insert band from pCRP5 was immobilized
on nitrocellulose and used in hybrid selection as previously described
(7) . CRP-specific RNA was isolated from 1.7 mg of PBMC total
RNA . A cDNA synthesis kit (Pharmacia Fine Chemicals, Pis-
cataway, NJ) was used to synthesize HScDNA from the hybrid-
selectedPBMC RNA . The HScDNA was ligated into the EcoRl
cloning site ofA ZAPII (Stratagene Cloning Systems, LaJolla,CA)
and transfected into Escherichia coli strain XLI-Blue (Stratagene
Cloning Systems) .
Identification of HScDNA1, HScDNA3, and HScDNA8.
￿
An
ofigolabeling kit (Pharmacia Fine Chemicals) was used to radiolabel
the purified 1.6-kb Pstl insert band from pCRP5 with 3'P-dCTP.
A probe with specific activity of 1.9 x 10' cpm/P,g of fragment
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that contained 0 .1, 1.0, or 10 P.1 of the HScDNA library. A DNA
hybridization method (8) was used to screen the nitrocellulose lifts
with thepCRP5 insert probe. 12 positiveHScDNA clones identified
from the autoradiogram of the HScDNA library screening were
plaque purified, and their size was determined. The three largest
clones, HScDNA1, HScDNA3, and HScDNA8, contain EcoRI
inserts of 1.0, 1.6, and 0.8 kb, respectively, and were characterized
further by sequence analysis.
Sequence Analysis of HScDNA1, HScDNA3, and HScDNA8 .
Both strands of thecDNA insert fragment from HScDNA3 were
subcloned into M13mp18 and M13mp19 . Nested deletion subclones
of both strands were constructed using the Cyclone I Biosystem
(International Biotechnologies, Inc., New Haven, CT) . The 5' limit
ofHScDNA8 was determined by subcloning thecDNA insert into
MP13mp18 and sequencing. The 5' limit ofHScDNAI was deter-
mined by sequencing this recombinant X ZAPII clone directly.
Single-stranded DNA templates prepared from M13 subclones or
directly from the recombinant X ZAPII clone were sequenced by
a dideoxy chain termination method using the Sequenase kit (United
States Biochemical Corp., Cleveland, OH) .A universal M13 primer
(provided in the Sequenase kit) was used in the sequencing reac-
tions of the M13 subclones. The T3 primer (Stratagene Cloning
Systems) was used in the sequencing reactions of recombinant A
ZAPII clones .
Results and Discussion
Our earlier studies demonstrated that anti-CRP im-
munoprecipitates a surface peptide from 1171- and IIr2-stimu-
lated lymphocytes (2) . This peptide is not acquired exogenously
from CRP found in serum but is synthesized by the lym-
phocytes (2) . Since the only known site of CRP synthesis
is the hepatocyte, we set out to determine if the anti-CRP
binding peptide produced by PBLs is CRP or an antigeni-
cally related peptide. The isolation and nucleotide sequence
of pCRP5, a 1.6-kb CRP-specific cDNA synthesized from
human liver RNA, was previously reported (6) . RNA was
isolated from unstimulated human PBMC and was hybrid
selected using pCRP5 . It was then converted into cDNA
and cloned into the EcoRI cloning site of X ZAPII phage
to construct HScDNA clones. When the HScDNA clones
were screened with radiolabeled pCRP5, we found that the
liver cDNA hybridized strongly to three PBMC clones,
HScDNA1, HScDNA3, and HScDNA8, which contained
cDNA inserts of 1.0, 1.6, and 0.8 kb, respectively.
A partial nucleotide sequence analysis was performed on
the smaller clones, HScDNA8 and HScDNA1, to determine
whether these clones represent the known CRP transcript
or a CRP-related transcript . We sequenced 304 nucleotides
from the 5' end ofHScDNA8 and 115 nucleotides from the
5' end ofHScDNA1 . When these sequences were compared
to pCRP5, we found that the 0.8-kb insert of HScDNA8
is homologous to the 5' end of pCRP5, while the 1.0-kb
insert ofHScDNA1 is homologous to the 3' end ofpCRP5
(Fig. 1) . The CRP gene contains a 278-bp intervening se-
quence that is defined by nucleotides 330-607 (6) . The ab-
sence of nucleotides 330-607 from HScDNA8 (Fig. 1) demon-
strates that the insert contained in HScDNA8 represents
a PBMC transcript and not PBMC genomic DNA, which
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Figure 1 .
￿
Alignment ofHScDNA clones to pCRP5 and theCRP gene .
The above map illustrates the alignment of the PBMC cDNA clones
HScDNA1, HScDNA3, and HScDNA8 to thelivercDNA clone, pCRP5,
and a fragment ofhuman genomicDNA containing the functionalCRP
gene (6) . The numbersindicate the 5' and 3' nucleotide limits of the cDNAs
and the genomic fragment . The arrows indicate the direction and portion
ofHScDNA1 and HScDNA8 sequenced, whereas the entire sequence of
HScDNA3 was determined . (/) The absence ofthe intervening sequence
(P70) from the cDNA clones. (*) The presence of a single nucleotide
substitution at position 1056 of the cDNA clones . The PBMC cDNA
clonescontain aG at this position while the livercDNA clone contains anA.
may have contaminated our hybrid selection and cloning
procedures. With one exception the nucleotides sequenced
from HScDNA1 and HScDNA8 display 100% homology
to pCRP5 . The exception is a substitution located at posi-
tion 1056 . HScDNA1 contains a G at this position while
pCRP5 contains an A (Fig. 2) . The nucleotide homology
ofHScDNA1 and HScDNA8 topCRP5 (and thus, the CRP
gene), along with the absence of the intervening sequence
from HScDNA8, indicate that these two HScDNA clones
represent PBMC transcripts of the CRP gene .
Although our results indicate that HScDNA1 and HSc-
DNA8 represent CRP transcripts, they do not eliminate the
possibility that our HScDNA clones were derived from frag-
ments ofpCRP5 thatmay have been eluted from the nitrocel-
lulose during the hybrid selection step, rather than from PBMC
transcripts . Since the entire CRP transcript is not represented
by pCRP5, the ends of our largest clone, HScDNA3, were
sequenced to determine ifthey contained any portions of the
CRP transcript that are not present in pCRP5 . Our data
show that the 5' limit ofHScDNA3 extends five nucleotides
beyond the 5' limit ofpCRP5 (Fig. 1) . Also, HScDNA3 con-
tains an additional 23 nucleotides on the 3' end that are not
present in pCRP5 (Fig. 1) . These additional nucleotides ob-
served in HScDNA3 are homologous to the corresponding
nucleotides of the CRP gene (Fig. 2) and confirm that
HScDNA3 is not derived from pCRP5 . Furthermore, since
HScDNA3 lacks the intervening sequence it is not derived
from genomic DNA (Fig . 1), but rather from aPBMC tran-
script .
The human genome contains a single copyCRP gene and
a pseudogene ; these display 50-80% region specific identity
(9) . Since the complete nucleotide sequence of HScDNA3
is >99% homologous to the CRP gene with all but 20 of
the 1,645 nucleotides of HScDNA3 being identical to the
sequence oftheCRP gene (99% identity), we conclude that
these HScDNA clones are not transcripts of the pseudogene
(Fig. 2) . The reduced homology in the last 15 nucleotides
of HScDNA3 may reflect the limitation of the polymerase
used for cDNA synthesis or genetic polymorphism . Alter-
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natively, HScDNA3 might have been damaged as a result
ofa fragmentation that may have occurred in this region during
cloning. The cDNA synthesis was initiated from a poly(T)
primer annealed to PBMC RNA. No poly(A) tail is observed
in HScDNA3, suggesting that this cDNA did fragment.
Nevertheless, the extensive nucleotide homology between
HScDNA3 and the coding region of the CRP gene verifies
that PBMC transcribe the CRP gene.
While hepatocytes express secreted CRP, we provided evi-
dence in a previous report that shows that CRP expressed
by peripheral blood cells is a membrane protein that does
not appear to be secreted (2, 3). Therefore, we examined the
deduced amino acid sequence of HScDNA3 to determine if
it has an alternate or additional transmembrane region that
pCRP5 does not have or any other differences that may ac-
count for the expression of a membrane peptide by periph-
eral blood cells and a secreted peptide by liver cells from the
same CRP gene. The only difference found near the 3' end
of the translated region is located at position 1056 (Fig. 2).
HScDNA3, as well as HScDNA1, have a G substituted for
the A observed at this position in pCRP5. However, this
is a neutral substitution that does not change the amino acid
coded for by the affected codon. It is, therefore, unlikely that
this nucleotide difference allows the expression of membrane
CRP by lymphocytes. Other sequence differences were ob-
served in the 3' untranslated region of HScDNA3 as com-
pared with pCRP5. These include the addition of a single
C after nucleotide 1364, the addition oftwo Gs after nucleo-
tide 1654, and the substitution of a C for an A at position
1684 (Fig. 2). Since nucleotides 1364, 1654, and 1684 are
located in the 3' untranslated region of the CRP transcript,
these differences are unlikely to account for the expression
of variant forms of the CRP peptide by different cell types.
Therefore, the nucleotide sequence of HScDNA3 suggests
that the CRP peptide expressed by peripheral blood cellshas
a primary structure identical to the pre-CRP peptide expressed
A
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Comparison ofHScDNAl
to pCRP5 andthegenomic CRP gene.
The map illustrates the alignment ofour
largest PBMC cDNA done, HScDNA3,
to the liver cDNA clone, pCRP5, and
to a fragment ofhuman genomic DNA
containing the functional CRP gene.
Only the nucleotides ofHScDNA3 that
differ from pCRP5 or the genomic
CRP clone are shownand indicated (*)
for substitutions or (+) for additions.
The thick solid lines indicate the coding
region, whichbegins with astart codon
at position 269 and ends with a stop
codon located at position 1219. (/) The
absence of an intervening sequence
defined by nucleotides 330-607 from the
cDNA clones. The thin solid lines in-
dicate untranslated regions. The dotted
line indicates an untranscribed region.
The complete sequence of HScDNA3
has been submitted to the EMBL Data
Library under accession number X56692.
by livercells. Although PBMC do not appear to add a trans-
membrane region or alter the COON terminus ofthe CRP
transcript, other mechanisms, such as usage of a phosphati-
dylinositol glycan anchor, could account for its presence as
a membrane protein. Clearly, variations in the processing and
assembly of CRP subunits, variations in other membrane pro-
teins, or variations in the signals received by cells could also
account for the expression of a membrane protein by periph-
eral blood cells and a secreted protein by liver cells from a
single CRP gene.
While it is unlikely that the few nucleotide differences ob-
served between our HScDNA clones and pCRP5 or the CRP
gene play a role in modifying the form of the CRP peptide
expressed in PBMC, they may represent genetic variations
within the CRP gene. This is supported by the finding that
when we compared the nucleotide sequence ofour HScDNA
clones with the CRP gene sequence reported by Goldman
and coworkers (9, 10), rather than to the sequence ofpCRP5
and the CRP gene reported by Woo et al. (6), we found that
our sequence is identical to the CRP gene at positions 1056
and 1684. There appear to be several genetic variations within
the CRP gene as demonstrated by sequence discrepancies
reported by various investigators at positions 1056, 1444, and
1684 of the CRP gene and CRP-specific cDNA clones.
Goldman et al. (9) previously suggested this when he reported
variations in the length ofthe polyGT stretch located within
the intervening sequence of the CRP gene.
Although PBLs and liver cells may synthesize identical
pre-CRP peptides, the CRP molecule expressed by periph-
eral blood cells may differ in tertiary structure from the ma-
ture CRP molecule secreted by the liver. Immunofluorescent
studies showed that a CRP epitope that is present on un-
processed CRP and not on serum CRP is preferentially ex-
pressed on lymphocytes (11). Perhaps the pre-CRP peptide
synthesized by PBMC is incompletely processed or reacts with
cellular factors that result in the expression of a conforma-tionally altered molecule that contains a region that is cryptic
in the pentameric form of CRP found in the serum . The
newly exposed region may function as a membrane anchor,
associate with a phosphatidylinositol glycan anchor, or as-
sociate with some other protein present in the membrane.
Many of the activities attributed to CRP involve the im-
mune response. It seems logical that hepatocytes might syn-
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